Drugs / Silver Colloid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02403479 | Dec 2015 → Mar 2016 | chronic rhinosinusitis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Silver Colloid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02403479 ↗ |
| Known as | Sovereign Silver Mineral Supplement | “The commercially available silver colloid product, Sovereign Silver Mineral Supplement, will be used.” NCT02403479 ↗ |
| Route | Intranasal | “Route= Topical intra-nasal spray” NCT02403479 ↗ |